Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Net Issuance of Preferred Stock : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Tianjin Pharmaceutical Da Ren Tang Group's net issuance of preferred for the three months ended in Mar. 2024 was ¥0 Mil. The number is 0, which means that Tianjin Pharmaceutical Da Ren Tang Group has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Tianjin Pharmaceutical Da Ren Tang Group's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Tianjin Pharmaceutical Da Ren Tang Group Net Issuance of Preferred Stock Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Net Issuance of Preferred Stock Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Tianjin Pharmaceutical Da Ren Tang Group Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Tianjin Pharmaceutical Da Ren Tang Group Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Executives

Li Li Qun	Director
Ni Zhen Guo	senior management
Yu Hong	Directors, senior managers
Zhou Hong	Directors, senior managers
Zhang Jian	senior management
Niu Sheng Fang	senior management
Wang Xin	senior management
Wang Mai	Director
Jiao Yan	senior management
Hao Fei Fei	Director
Zhang Bao Tong	senior management
Wang Zhi Qiang	senior management
Liang Xiu Qin	senior management
Li Jia Sheng	Supervisors
Zhang Hong Kui	Director

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines